Since we currently receive no info from REVO, It would be great if people here "in the know" (who talk with Ron Carter or Ross Helfer, or possibly the SEC) would be willing to reveal anything they know about the following, -for the benefit of all shareholders.
1) Why did Ron Carter leave REVO? Did he leave voluntarily, or was he forced out?
2) Does Ron Carter still own all of the original REVO patents?
3) Is the BOD eventually planning on appointing a new CEO (besides interim CEO Ali)?
4) Does REVO have any plans to update its financial statements anytime soon, or file form 211 to get off the grey markets and resume normal trading? Or, are they just waiting for a possible buyout?
5) What (Eyetalk365) lawsuits (on behalf of REVO) are currently ongoing, and which ones have been settled in the courts?
6) What is the proof for the REVO lawsuit trust fund, rumored to have been set up by Eyetalk365? How many more infringement lawsuits does Eyetalk365 plan to file? When does Eyetalk365 plan on giving REVO the money (40%) from the settled lawsuits that is supposedly being put into the trust fund?
7) Are REVO shareholders just expected to believe (forever on faith) that non-disclosure (NDA) agreements and secrecy about revenues (so as to not tip off infringers or companies that may be interested in a buyout of the patents) is the reason why REVO has "gone dark" and doesn't report anything to shareholders (see below)?
"The money from licensed partners is in a trust with Eyetalk365, and if any money whatsoever exchanges hands with REVO they have to report it. Reporting the infringement settlements will hinder negotiations with other infringers and show too many cards if there is a sale of the patents."
Note: I've been in other OTC companies that are suing patent infringers and they regularly report their income from infringement lawsuits in a 10Q on a quarterly basis (although they don't reveal anything else about their NDA agreements).
8) Is there any evidence of a REVO buyout or sale of the Carter/REVO patents in the works?
9) When can shareholders expect to HEAR SOMETHING, ANYTHING from REVO?
Would appreciate any answers you might have to any or all of these questions!
AI
